CoChat

Screening of Angiotensin-I Converting Enzyme Inhibitory Peptides Derived from Caulerpa lentillifera

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Peptides with angiotensin-I converting enzyme (ACE) inhibitory activity have received considerable interest due to their potential as antihypertensive agents and consumer concern over the safety of synthetic drugs. The objective of this study was to isolate ACE inhibitory (ACEI) peptides from Caulerpa lentillifera (known commonly as sea grape) protein hydrolysate. In this study, short-chain peptides were obtained after hydrolysis by various enzymes and subsequently by ultrafiltration. Thermolysin hydrolysate showed the highest ACEI activity. Bioassay-guided fractionation was performed using reversed-phase high performance liquid chromatography (RP-HPLC) to uncover the fraction 9 with the highest ACE inhibitory activity from thermolysin hydrolysate. Peptides in this fraction were further identified using liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis coupled with de novo sequencing, which gave two oligopeptides, FDGIP (FP-5) and AIDPVRA (AA-7). The identities and activities of these two peptides were further confirmed using synthetic peptides. Their IC50 values were determined as 58.89 ± 0.68 µM and 65.76 ± 0.92 µM, respectively. Moreover, the inhibition kinetics revealed that both FP-5 and AA-7 are competitive inhibitors. These activities were further explained using molecular docking simulation. The present study is the first report about ACEI peptides derived from Caulerpa lentillifera and it shows the potential for preventing hypertension and for functional food development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules23113005

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Angiotensin-I converting enzyme (ACE) inhibitory activities of Caulerpa lentillifera protein (CLP) hydrolysates digested by different enzymes. Each point is the mean of three determinations (n = 3) ± SD. Different letters labeled on the bar indicate significant difference. The concentration of each hydrolysate is 1 mg/mL, and Captopril (10 µM) is used as positive control.
Figure 1 Angiotensin-I converting enzyme (ACE) inhibitory activities of Caulerpa lentillifera protein (CLP) hydrolysates digested by different enzymes. Each point is the mean of three determinations (n = 3) ± SD. Different letters labeled on the bar indicate significant difference. The concentration of each hydrolysate is 1 mg/mL, and Captopril (10 µM) is used as positive control.CC BY · PubMed Central
Figure 2 Bioassay-guided fractionation. (A) Reversed-phase high performance liquid chromatography (RP-HPLC) chromatogram of Caulerpa lentillifera protein (CLP) hydrolysate hydrolyzed by thermolysin. It is divided into 12 fractions; (B) ACE inhibitory activities of 12 RP-HPLC fractions. Each point is the mean of the three determinations (n = 3) ± SD. Different letters labeled on the bar indicate significant difference (p < 0.05). The concentration for each fraction is 0.1 mg/mL, and captopril (10 µM) is used as positive control.
Figure 2 Bioassay-guided fractionation. (A) Reversed-phase high performance liquid chromatography (RP-HPLC) chromatogram of Caulerpa lentillifera protein (CLP) hydrolysate hydrolyzed by thermolysin. It is divided into 12 fractions; (B) ACE inhibitory activities of 12 RP-HPLC fractions. Each point is the mean of the three determinations (n = 3) ± SD. Different letters labeled on the bar indicate significant difference (p < 0.05). The concentration for each fraction is 0.1 mg/mL, and captopril (10 µM) is used as positive control.CC BY · PubMed Central
Figure 3 Identification of two peptides from RP-HPLC fraction 9. (A) Liquid chromatography-mass spectrometry (LC-MS) chromatogram of RP-HPLC fraction 9 (top). Selective ion chromatogram of m/z 548.2700 (FP-5, peak at tR = 35.96 min) (down); (B) Tandem mass spectrometry (MS/MS) spectrum of FP-5 (m/z 548.2700); (C) LC-MS chromatogram of RP-HPLC fraction 9 (top). Selective ion chromatogram of m/z 741.3163 (AA-7, peak at tR = 37.53 min) (down); (D) MS/MS spectrum of AA-7 (m/z 741.3163).
Figure 3 Identification of two peptides from RP-HPLC fraction 9. (A) Liquid chromatography-mass spectrometry (LC-MS) chromatogram of RP-HPLC fraction 9 (top). Selective ion chromatogram of m/z 548.2700 (FP-5, peak at tR = 35.96 min) (down); (B) Tandem mass spectrometry (MS/MS) spectrum of FP-5 (m/z 548.2700); (C) LC-MS chromatogram of RP-HPLC fraction 9 (top). Selective ion chromatogram of m/z 741.3163 (AA-7, peak at tR = 37.53 min) (down); (D) MS/MS spectrum of AA-7 (m/z 741.3163).CC BY · PubMed Central
Figure 4 The IC50 values of the two potent ACE inhibitory (ACEI) peptides. (A) The IC50 determination for FP-5; (B) The IC50 determination for AA-7. The IC50 values were calculated from triplicate data using Graphpad Prism 6.0 by a nonlinear regression.
Figure 4 The IC50 values of the two potent ACE inhibitory (ACEI) peptides. (A) The IC50 determination for FP-5; (B) The IC50 determination for AA-7. The IC50 values were calculated from triplicate data using Graphpad Prism 6.0 by a nonlinear regression.CC BY · PubMed Central
Figure 5 The inhibition kinetics of FP-5 and AA-7. (A) The Lineweaver–Burk plot of FP-5 against ACE; (B) The Lineweaver–Burk plot of AA-7 against ACE.
Figure 5 The inhibition kinetics of FP-5 and AA-7. (A) The Lineweaver–Burk plot of FP-5 against ACE; (B) The Lineweaver–Burk plot of AA-7 against ACE.CC BY · PubMed Central
Figure 6 Pre-incubation experiment of FP-5 and AA-7. The error bars represent the standard deviation (** indicates a significant difference compared to control with p < 0.05). The concentration for each peptide is 100 μM.
Figure 6 Pre-incubation experiment of FP-5 and AA-7. The error bars represent the standard deviation (** indicates a significant difference compared to control with p < 0.05). The concentration for each peptide is 100 μM.CC BY · PubMed Central
Figure 7 Molecular docking simulation between ACEI peptides and ACE. (A) Proposed binding interaction between FP-5 and ACE residues; (B) Proposed binding interaction between AA-7 and ACE residues. The best pose was stabilized by hydrogen bonds shown by blue and green lines.
Figure 7 Molecular docking simulation between ACEI peptides and ACE. (A) Proposed binding interaction between FP-5 and ACE residues; (B) Proposed binding interaction between AA-7 and ACE residues. The best pose was stabilized by hydrogen bonds shown by blue and green lines.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. Katzung, B.G., Masters, S.B., and Trevor, A.J. (2012). Basic and Clinical Pharmacology, McGraw-Hill. [12th ed.].

Cited by

See all 48

Metadata

Authors
Joel, C. H., Sutopo, C. C. Y., Prajitno, A., Su, J.-H., & Hsu, J.-L.
Affiliations
  • National Pingtung University of Science and Technology (TW)
  • University of Brawijaya (ID)
  • National Museum of Marine Biology and Aquarium (TW)
Corresponding author
Hsu, Jue-Liang
Venue
Molecules
Publisher
MDPI AG
Published
2018-11-16
Volume
23
Issue
11
Pages
3005
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2900557905
Cited by
48
References
36
Citations by year
2026: 6 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 13 · 2021: 2 · 2020: 4 · 2019: 6
FWCI
1.07
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Taiwan MOST (MOST 106-2113-M-020-001 & MOST 107-3017-F-020-001-)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
Keywords
angiotensin I-converting enzyme inhibitory peptides, Caulerpa lentillifera, sea grapes, protein hydrolysates, bioassay-guided fractionation, peptide identification, competitive inhibition, antihypertensive drugs, functional foods, marine algae
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Chemical Fractionation, Peptidyl-Dipeptidase A, Peptide Fragments, Plant Extracts, Protein Hydrolysates, Caulerpa, High-Throughput Screening Assays, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening of Angiotensin-I Converting Enzyme Inhibitory Peptides Derived from Caulerpa lentillifera. https://app.cochat.ai/papers/10.3390/molecules23113005
The paper
Joel, C. H., Sutopo, C. C. Y., Prajitno, A., Su, J.-H., & Hsu, J.-L. (2018). Screening of Angiotensin-I Converting Enzyme Inhibitory Peptides Derived from Caulerpa lentillifera. Molecules. https://doi.org/10.3390/molecules23113005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.